BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25188375)

  • 21. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of macronutrient content of meals on postprandial glucose control in the context of closed-loop insulin delivery: A randomized cross-over study.
    Gingras V; Bonato L; Messier V; Roy-Fleming A; Smaoui MR; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2018 Nov; 20(11):2695-2699. PubMed ID: 29931719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of optimal insulin administration timing for standard carbohydrates-rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross-over randomized study.
    Tucholski K; Sokołowska M; Tucholska D; Kamińska H; Jarosz-Chobot P
    J Diabetes Investig; 2019 Sep; 10(5):1237-1245. PubMed ID: 30768859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Effect of Carbohydrate Intake on Postprandial Glucose in Patients With Type 1 Diabetes Treated With Insulin Pumps.
    James ML; Green L; Amiel SA; Choudhary P
    J Diabetes Sci Technol; 2016 Nov; 10(6):1287-1293. PubMed ID: 27137456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study).
    De Palma A; Giani E; Iafusco D; Bosetti A; Macedoni M; Gazzarri A; Spiri D; Scaramuzza AE; Zuccotti GV
    Diabetes Technol Ther; 2011 Apr; 13(4):483-7. PubMed ID: 21355715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm.
    Zisser H; Palerm CC; Bevier WC; Doyle FJ; Jovanovic L
    J Diabetes Sci Technol; 2009 May; 3(3):487-91. PubMed ID: 20144286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement.
    Fushimi E; Colmegna P; De Battista H; Garelli F; Sánchez-Peña R
    J Diabetes Sci Technol; 2019 Nov; 13(6):1035-1043. PubMed ID: 31339059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
    Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
    Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy.
    Bondia J; Dassau E; Zisser H; Calm R; Vehí J; Jovanovič L; Doyle FJ
    J Diabetes Sci Technol; 2009 Jan; 3(1):89-97. PubMed ID: 20046653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy.
    Gross TM; Kayne D; King A; Rother C; Juth S
    Diabetes Technol Ther; 2003; 5(3):365-9. PubMed ID: 12828818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
    Sala-Mira I; Garcia P; Díez JL; Bondia J
    Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin delivery patterns required to maintain postprandial euglycemia in type 1 diabetes following consumption of traditional Egyptian Ramadan Iftar meal using insulin pump therapy: A randomized crossover trial.
    Elbarbary NS; Elhenawy YI; Ali ARR; Smart CE
    Pediatr Diabetes; 2022 Dec; 23(8):1628-1634. PubMed ID: 36285573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 35. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
    Gingras V; Taleb N; Roy-Fleming A; Legault L; Rabasa-Lhoret R
    Diabetes Obes Metab; 2018 Feb; 20(2):245-256. PubMed ID: 28675686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
    Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
    Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
    O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
    Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
    Piechowiak K; Dżygało K; Szypowska A
    Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-protein meals require 30% additional insulin to prevent delayed postprandial hyperglycaemia.
    Paterson MA; Smart CEM; Howley P; Price DA; Foskett DC; King BR
    Diabet Med; 2020 Jul; 37(7):1185-1191. PubMed ID: 32298501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.